CN1167701C - 制备噁唑烷酮胺的方法 - Google Patents

制备噁唑烷酮胺的方法 Download PDF

Info

Publication number
CN1167701C
CN1167701C CNB011330031A CN01133003A CN1167701C CN 1167701 C CN1167701 C CN 1167701C CN B011330031 A CNB011330031 A CN B011330031A CN 01133003 A CN01133003 A CN 01133003A CN 1167701 C CN1167701 C CN 1167701C
Authority
CN
China
Prior art keywords
phenyl
mixture
alcohol
alkyl
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB011330031A
Other languages
English (en)
Chinese (zh)
Other versions
CN1381454A (zh
Inventor
Ba
B·A·佩尔曼
W·R·佩拉特
�Ͱ��ж�
M·R·巴巴切恩
P·R·曼尼内
D·S·托普斯
I
D·J·霍瑟
T·J·弗雷克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of CN1381454A publication Critical patent/CN1381454A/zh
Application granted granted Critical
Publication of CN1167701C publication Critical patent/CN1167701C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB011330031A 1996-04-11 1997-03-28 制备噁唑烷酮胺的方法 Expired - Fee Related CN1167701C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1549996P 1996-04-11 1996-04-11
US60/015,499 1996-04-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN97193658A Division CN1082953C (zh) 1996-04-11 1997-03-28 制备噁唑烷酮的方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNB031594743A Division CN1319952C (zh) 1996-04-11 1997-03-28 制备唑烷酮胺的方法

Publications (2)

Publication Number Publication Date
CN1381454A CN1381454A (zh) 2002-11-27
CN1167701C true CN1167701C (zh) 2004-09-22

Family

ID=21771765

Family Applications (3)

Application Number Title Priority Date Filing Date
CNB011330031A Expired - Fee Related CN1167701C (zh) 1996-04-11 1997-03-28 制备噁唑烷酮胺的方法
CNB031594743A Expired - Fee Related CN1319952C (zh) 1996-04-11 1997-03-28 制备唑烷酮胺的方法
CN97193658A Expired - Fee Related CN1082953C (zh) 1996-04-11 1997-03-28 制备噁唑烷酮的方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
CNB031594743A Expired - Fee Related CN1319952C (zh) 1996-04-11 1997-03-28 制备唑烷酮胺的方法
CN97193658A Expired - Fee Related CN1082953C (zh) 1996-04-11 1997-03-28 制备噁唑烷酮的方法

Country Status (24)

Country Link
US (1) US5837870A (enExample)
EP (2) EP1114819B1 (enExample)
JP (2) JP2000508312A (enExample)
KR (1) KR100530297B1 (enExample)
CN (3) CN1167701C (enExample)
AT (2) ATE209193T1 (enExample)
AU (1) AU706117B2 (enExample)
CA (1) CA2248143C (enExample)
CZ (2) CZ298060B6 (enExample)
DE (2) DE69709718T2 (enExample)
DK (2) DK0892792T3 (enExample)
ES (2) ES2166073T3 (enExample)
HU (1) HUP0500044A3 (enExample)
NO (2) NO311837B1 (enExample)
NZ (1) NZ332278A (enExample)
PL (1) PL192691B1 (enExample)
PT (2) PT1114819E (enExample)
RU (1) RU2176643C2 (enExample)
SG (1) SG85683A1 (enExample)
SI (1) SI0892792T1 (enExample)
SK (1) SK284703B6 (enExample)
TW (1) TW449593B (enExample)
WO (1) WO1997037980A1 (enExample)
ZA (1) ZA972983B (enExample)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
BR9910971A (pt) 1998-06-05 2001-02-13 Astrazeneca Ab Composto, processos para a preparação de um composto e para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto, e, composição farmacêutica
EP1008590B1 (en) * 1998-12-07 2006-10-11 Takasago International Corporation Process for preparing optically active oxazolidinone derivatives
PT1149089E (pt) 1999-02-01 2003-07-31 Upjohn Co Processo para preparar carbamatos tetra-hidrotiopirano-o-fluorados
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6413981B1 (en) 1999-08-12 2002-07-02 Ortho-Mcneil Pharamceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6297242B1 (en) 1999-08-12 2001-10-02 Ortho-Mcneil Pharmaceutical, Inc. N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
US6518285B2 (en) 1999-12-21 2003-02-11 Ortho Mcneil Pharmaceutical, Inc. Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
US6444813B2 (en) 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
AR027261A1 (es) * 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
WO2002002095A2 (en) 2000-06-30 2002-01-10 Pharmacia & Upjohn Company Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin
PE20020300A1 (es) * 2000-08-22 2002-05-10 Pharmacia Corp Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
US6288239B1 (en) 2000-09-19 2001-09-11 Board Of Trustees Operating Michigan State University 5-trityloxymethyl-oxazolidinones and process for the preparation thereof
AR031135A1 (es) 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
US20050032861A1 (en) * 2001-04-07 2005-02-10 Betts Michael John Oxazolidines containing a sulfonimid group as antibiotics
EP1380121B1 (en) 2001-04-20 2007-09-26 Pharmacia & Upjohn Company LLC Process to prepare oxazolidinones
ES2186550B2 (es) * 2001-06-27 2003-11-16 Vita Lab Nuevos derivados de oxazolidinonas como antibacterianos.
EP1578723A4 (en) * 2001-10-18 2006-11-02 Univ Michigan State Process for the preparation of oxazolidinones and method of use thereof
WO2003072141A1 (en) * 2002-02-22 2003-09-04 Pharmacia Corporation Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
TW200400055A (en) * 2002-02-22 2004-01-01 Pharmacia Corp Ophthalmic formulation with novel gum composition
PT1673370E (pt) * 2003-10-16 2009-11-05 Symed Labs Ltd Forma cristalina de linezolida
DE602004009344T2 (de) 2004-04-19 2008-07-10 Symed Labs Ltd., Hyderabad Neues verfahren zur herstellung von linezolid und verwandten verbindungen
US7429661B2 (en) * 2004-07-20 2008-09-30 Symed Labs Limited Intermediates for linezolid and related compounds
RU2008139612A (ru) * 2006-04-07 2010-04-20 Пфайзер Продактс Инк. (Us) Способ получения линезолида
CN100395270C (zh) * 2006-05-25 2008-06-18 湖北大学 线型聚苯乙烯支载的(4s)-5,5-二取代基噁唑烷酮及其制备方法和用途
EP2033960A3 (en) * 2007-09-04 2009-04-29 Dipharma Francis S.r.l. Linezolid crystalline hydrate form and linezolid salts
WO2009032294A2 (en) * 2007-09-06 2009-03-12 Teva Pharmaceutical Industries Ltd. Processes for the preparation of a linezolid intermediate, linezolid hydroxide
EP2163547A1 (en) 2008-09-16 2010-03-17 Unión Químico Farmacéutica, S.A. (UQUIFA) Process for the preparation of an oxazolidinone antibacterial agent and intermediates thereof
JP5561462B2 (ja) * 2009-09-17 2014-07-30 日東化成株式会社 漁網防汚塗料組成物、該組成物を用いて形成される防汚塗膜、該塗膜の形成方法、および該塗膜を表面に有する漁網、漁網用具又は水中構造物
US20130137864A1 (en) 2009-12-26 2013-05-30 Jayaraman Venkat Raman Process for the preparation of linezolid
WO2011080341A1 (en) 2010-01-04 2011-07-07 Enantia, S.L. Process for the preparation of rivaroxaban and intermediates thereof
EP2603505A1 (en) 2010-08-11 2013-06-19 Synthon BV Process for making linezolid
EP2690100A1 (en) 2010-08-11 2014-01-29 Synhton B.V. Process for making linezolid
JP2014500247A (ja) 2010-11-03 2014-01-09 ウォックハート リミテッド リン酸モノ−（１−｛４−［（ｓ）―５−（アセチルアミノメチル）−２−オキソ−オキサゾリジン−３−イル］−２，６−ジフルオロフェニル｝−４−メトキシメチルピペリジン−４−イル）エステルの調製方法
US9567307B2 (en) * 2011-01-07 2017-02-14 The Regents Of The University Of California Amination of aryl alcohol derivatives
CN102153521B (zh) * 2011-01-31 2012-09-12 宁波市鄞州百特佳医药科技有限公司 一种用于制备利奈唑胺的中间体及其制备方法
EP2593440A1 (en) 2011-02-24 2013-05-22 Lee Pharma Limited Anhydrous linezolid crystalline form-ii
PL2595968T3 (pl) 2011-02-24 2016-03-31 Lee Pharma Ltd Nowy sposób wytwarzania linezolidu i jego nowe produkty pośrednie
CN102321042B (zh) * 2011-07-18 2013-12-04 苏州敬业医药化工有限公司 3-取代苯基-5-羟甲基噁唑烷-2-酮的制备方法
CN102311402B (zh) * 2011-07-18 2013-08-21 苏州敬业医药化工有限公司 3-取代苯基-5-羟甲基噁唑烷-2-酮的制备方法
WO2013072923A1 (en) 2011-09-19 2013-05-23 Cadila Healthcare Limited Process for the preparation of crystalline linezolid
IN2014DN06213A (enExample) 2012-01-24 2015-10-23 Jubilant Life Sciences Ltd
CN103626712B (zh) * 2012-08-23 2016-06-01 重庆药友制药有限责任公司 一种用于制备利奈唑胺的中间体及其制备方法
WO2014071990A1 (en) 2012-11-09 2014-05-15 Synthon Bv Process for making linezolid
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide
WO2021184339A1 (en) 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent
CN119119019B (zh) * 2024-09-11 2025-11-11 遵义医科大学 一种杂环磺酰胺/磺酸酯衍生物及其制备方法、应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA681830A (en) * 1964-03-10 X. Markley Francis Process for 5-(aryloxymethyl)-2-oxazolidinones
US3547951A (en) * 1969-06-17 1970-12-15 Waldo R Hardie 1,3-dioxolan-4-yl-alkyl guanidines
FR2315925A1 (fr) * 1975-07-04 1977-01-28 Nippon Chemiphar Co Nouveaux derives de 5-benzyle-2-oxazolidone, leur procede de preparation et leur application en therapeutique
FR2356422A1 (fr) * 1976-03-01 1978-01-27 Delalande Sa Nouveaux hydroxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application en therapeutique
LU80081A1 (fr) * 1977-08-26 1979-05-15 Delalande Sa Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
JPS6014032B2 (ja) * 1978-01-20 1985-04-11 日本ケミフア株式会社東京 ５‐フエネチル‐２‐オキサゾリドン誘導体およびその製法
US4340606A (en) * 1980-10-23 1982-07-20 E. I. Du Pont De Nemours And Company 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2500450A1 (fr) * 1981-02-25 1982-08-27 Delalande Sa Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
US4461773A (en) * 1982-09-15 1984-07-24 E. I. Dupont De Nemours And Company P-Oxooxazolidinylbenzene compounds as antibacterial agents
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5182403A (en) * 1988-09-15 1993-01-26 The Upjohn Company Substituted 3(5'indazolyl) oxazolidin-2-ones
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
US5225565A (en) * 1988-09-15 1993-07-06 The Upjohn Company Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones
US5231188A (en) * 1989-11-17 1993-07-27 The Upjohn Company Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents
JP2908510B2 (ja) * 1990-04-20 1999-06-21 イハラケミカル工業株式会社 ベンジルアミン類の製造方法
EP0530812B1 (en) * 1991-09-05 1996-05-22 Nippon Paint Co., Ltd. Thermosetting resinous composition containing polyfunctional oxazolidinone component and polyamine component
CA2119556C (en) * 1991-11-01 2004-07-06 Michael Robert Barbachyn Substituted aryl- and heteroaryl-phenyloxazolidinones
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
RU2134692C1 (ru) * 1994-10-26 1999-08-20 Фармация Энд Апджон Компани Антимикробные фенилоксазолидиноны
MX9703543A (es) * 1994-11-15 1997-08-30 Upjohn Co Antibacterianos de oxazina biciclica y oxazolidinona tiazina.
NZ306310A (en) * 1995-05-11 2001-05-25 Upjohn Co Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones

Also Published As

Publication number Publication date
AU706117B2 (en) 1999-06-10
EP0892792A1 (en) 1999-01-27
DE69709718D1 (de) 2002-02-21
JP2000508312A (ja) 2000-07-04
EP1114819A1 (en) 2001-07-11
AU2318297A (en) 1997-10-29
DK0892792T3 (da) 2002-04-02
ATE383347T1 (de) 2008-01-15
KR20040066189A (ko) 2004-07-23
TW449593B (en) 2001-08-11
ZA972983B (en) 1998-10-08
CZ200788A3 (cs) 2017-01-25
CN1215393A (zh) 1999-04-28
HK1061241A1 (en) 2004-09-10
CA2248143C (en) 2008-10-07
US5837870A (en) 1998-11-17
CZ298060B6 (cs) 2007-06-06
NO20015253L (no) 1998-12-09
SG85683A1 (en) 2002-01-15
NO20015253D0 (no) 2001-10-26
SI0892792T1 (en) 2002-06-30
DK1114819T3 (da) 2008-04-14
PT1114819E (pt) 2008-02-28
JP2008239621A (ja) 2008-10-09
DE69709718T2 (de) 2002-06-20
PL329295A1 (en) 1999-03-15
NO984737L (no) 1998-12-09
NZ332278A (en) 2000-05-26
CN1319952C (zh) 2007-06-06
PL192691B1 (pl) 2006-11-30
RU2176643C2 (ru) 2001-12-10
CN1496983A (zh) 2004-05-19
NO984737D0 (no) 1998-10-09
PT892792E (pt) 2002-05-31
NO312728B1 (no) 2002-06-24
SK133698A3 (en) 1999-06-11
DE69738457T2 (de) 2008-12-24
DE69738457D1 (de) 2008-02-21
ES2298198T3 (es) 2008-05-16
ES2166073T3 (es) 2002-04-01
EP0892792B1 (en) 2001-11-21
HU0500044D0 (en) 2005-03-29
SK284703B6 (sk) 2005-09-08
HUP0500044A3 (en) 2005-09-28
NO311837B1 (no) 2002-02-04
CA2248143A1 (en) 1997-10-16
HK1018785A1 (en) 2000-01-07
CZ287198A3 (cs) 1999-02-17
CN1381454A (zh) 2002-11-27
CN1082953C (zh) 2002-04-17
ATE209193T1 (de) 2001-12-15
EP1114819B1 (en) 2008-01-09
KR100530297B1 (ko) 2005-11-22
WO1997037980A1 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
CN1167701C (zh) 制备噁唑烷酮胺的方法
CN1075070C (zh) 取代的氮－及二氮杂环庚烷及－环辛烷化合物及其用途
CN1052231C (zh) 2－氧代－5－噁唑烷酮甲基化合物,它们的制备方法及含它们的药物组合物
CN1310907C (zh) 杂环化合物和以其为有效成分的抗肿瘤药
CN1304382C (zh) 用于治疗炎性、免疫或心血管疾病的新的p2x7受体拮抗剂
CN1095839C (zh) 4,5－二芳基噁唑衍生物
CN1106806A (zh) 粘结受体拮抗剂iii
HK1041483A1 (en) Bicyclic nitrogen heterocycles
CN1215724A (zh) 新颖化合物
CN1067053C (zh) 单环β－内酰胺类抗生素衍生物的中间体的制备方法
CN1520412A (zh) 作为抗菌剂的新噁唑烷酮衍生物
CN1703409A (zh) 新紫杉烷和用途及制备方法
CN101065379A (zh) 制备4,5－二氢－吡唑并[3,4－c]吡啶－2－酮的方法
CN1639133A (zh) 新抗菌化合物、其制备方法和含有它们的药物组合物
CN1267435C (zh) 制备氧杂双哌啶的新方法
CN1291979C (zh) 咪唑化合物及其作为腺苷脱氨酶抑制剂的用途
CN1079745A (zh) 新的9-氟-7-氧代-7H-吡啶并[1，2，3-d，e][1，4]苯并嗪-6-羧酸及其酯
CN1108648A (zh) 新型的取代炔丙基氮杂环丁酮的制备方法
CN1052003C (zh) 3－酰基－2－羟吲哚－1－甲酰胺类抗炎前药
CN1028531C (zh) 1-氧杂-2-氧代-8-氮杂螺[4，5]癸烷衍生物及其盐的制备方法
CN1548438A (zh) 2-取代苯基-6,8-二烃基-3H-咪唑[1,5α][1,3,5]三嗪-4-酮衍生物,其制备方法及其药物用途
HK1061241B (en) Process to prepara oxazolidinones
CN1127757A (zh) 新四氢吡喃化合物，它们的制备以及含这类化合物的药物组合物
HK1018785B (en) Process to prepare oxazolidinones
CN1926097A (zh) 杂芳基－烷基氨基甲酸酯的衍生物、其制备方法和作为faah酶抑制剂的用途

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040922